BALFX
Price
$41.06
Change
+$0.10 (+0.24%)
Updated
Jun 2 closing price
Net Assets
278.87B
VWELX
Price
$47.63
Change
+$0.03 (+0.06%)
Updated
Jun 2 closing price
Net Assets
121.34B
Interact to see
Advertisement

BALFX vs VWELX

Header iconBALFX vs VWELX Comparison
Open Charts BALFX vs VWELXBanner chart's image
BALFX vs VWELX Comparison Chart in %
View a ticker or compare two or three
VS
BALFX vs. VWELX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALFX is a Hold and VWELX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALFX has more cash in the bank: 279B vs. VWELX (121B). VWELX pays higher dividends than BALFX: VWELX (1.95) vs BALFX (1.75). BALFX was incepted earlier than VWELX: BALFX (25 years) vs VWELX (97 years). BALFX (0.61) is less costly to investors than VWELX (0.24). VWELX is a more actively managed with annual turnover of: 62.00 vs. BALFX (50.00). BALFX has a lower initial minimum investment than VWELX: BALFX (250) vs VWELX (3000). BALFX annual gain was more profitable for investors over the last year : 17.70 vs. VWELX (10.17). BALFX return over 5 years is better than : 35.27 vs. VWELX (5.00).
BALFXVWELXBALFX / VWELX
Total Expense Ratio0.610.24254%
Annual Report Gross Expense Ratio0.610.24254%
Fund Existence25 years97 years-
Gain YTD9.6736.833142%
Front LoadN/AN/A-
Min. Initial Investment25030008%
Min. Initial Investment IRAN/AN/A-
Net Assets279B121B231%
Annual Yield % from dividends1.751.9590%
Returns for 1 year17.7010.17174%
Returns for 3 years45.4322.17205%
Returns for 5 years35.275.00705%
Returns for 10 years85.7938.03226%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIPSX38.78N/A
N/A
ProFunds Biotechnology UltraSector Svc
VITPX125.26N/A
N/A
Vanguard Instl Ttl Stk Mkt Idx InstlPls
HFMCX21.38N/A
N/A
Hartford MidCap A
HWMIX67.23N/A
N/A
Hotchkis & Wiley Mid-Cap Value I
GSEPX73.92N/A
N/A
Goldman Sachs US Equity Insights P